Bundamedik Tbk vs Budi Starch Sweetener Tbk — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Budi Starch Sweetener Tbk trades at Rp206 (market cap 935.79B, 20.1K 24h volume). The key difference: Bundamedik Tbk is the larger of the two by market cap, and Bundamedik Tbk is more actively traded (536.7K versus 20.1K). Which is the better fit depends on your goals.
| BMHS | BUDI | |
|---|---|---|
Market Cap | 1.51T | 935.79B |
Volume | 536.7K | 20.1K |
Lot | 5.37K | 201 |
Turnover | 93.41M | 4.18M |
Average Price | 174.05 | 207.72 |
Value | 93.41M | 4.18M |
Indicative Equilibrium Price | 176 | 208 |
Indicative Equilibrium Volume | 100 | 13.8K |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Budi Starch & Sweetener Tbk (the Company) formerly Budi Acid Jaya (BAJ) was established based on Notarial Deed No. 15 dated January 15, 1979 of Henk Limanow, SH., public notary in Jakarta. PT Budi Starch & Sweetener Tbk is the world`s largest tapioca starch producer. BAJ is an integrated cassava based manufacturer : citric acid, modified tapioca starch and monosodium glutamate (MSG). It also produces sulphuric acid and poly propelene woven bag.
Read more on BUDI →